Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs.
Maeda H, Khatami M. · 2018
Read Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs. by Maeda H, Khatami M. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5852245.txt.
Description
Maeda and Khatami dissect six decades of failure against solid tumors. Their analysis appeared in Clinical and Translational Medicine. The authors put the failure rate of cancer therapies near 90 percent. They blame a reductionist hunt for single molecular targets.
Tumors, they argue, are chaotic and mutate without pause. Drugs tuned to one target miss the moving whole. Poor delivery to tumor tissue compounds the problem. Costs, meanwhile, have grown unsustainable for health systems. The pair question vaccine hype on similar grounds. They close by urging fundamentally different strategies. Leukemias, they note, are the rare exception to the pattern.
Catalog record
| CREATOR | Maeda H, Khatami M. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 102 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |